Detection of copy number variations by chromosomal microarray analysis in disorders of sex development of unexplained molecular etiology and association with clinical findings

MURAT ÇAĞLAR KARATAŞ; Ferda EVİN; Tahir ATİK; AYSUN ATA; EREN ER; Erhan PARILTAY; Aslı ECE SOLMAZ; Ruhsar Damla GÖKŞEN; Şükran DARCAN; Samim ÖZEN

doi:10.1007/s12020-025-04419-0

Detection of copy number variations by chromosomal microarray analysis in disorders of sex development of unexplained molecular etiology and association with clinical findings

Makaleler > Tam Makale · 2025

Yazarlar: MURAT ÇAĞLAR KARATAŞ, Ferda EVİN, Tahir ATİK, AYSUN ATA, EREN ER, Erhan PARILTAY, Aslı ECE SOLMAZ, Ruhsar Damla GÖKŞEN, Şükran DARCAN, Samim ÖZEN

ENDOCRINE, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2025, cilt 90, ss 15-25

DOI: 10.1007/s12020-025-04419-0

Özet

PurposeDespite advances in genetic diagnostics, the molecular cause of a significant proportion of DSDs remains unknown. The aim of this study was to identify copy number variations (CNVs) using chromosomal microarray analysis (CMA) technology in DSD patients with previously undetected molecular genetic etiology and to investigate their phenotypic associations with these variations.MethodsThis study included DSD cases without chromosomal abnormalities and without any variants detected by sequence analysis methods, including whole-exome sequencing analysis. We evaluated variant pathogenicity according to the American College of Medical Genetics and Genomics guidelines and recorded the phenotypic findings of the cases. All pathogenic variants were subjected to segregation analysis.ResultsOf the 20 patients included in the study, 16 (80%) were classified as 46,XY DSD and 4 (20%) as 46,XX DSD. Initial clinical diagnoses in this 46,XX DSD group included gonadal dysgenesis in two patients (50%) and androgen excess in the remaining two (50%). Among the 46,XY DSD patients, five patients (31.25%) were presumed to be androgen insensitive, nine (56.25%) were diagnosed with defects in androgen biosynthesis, and two (12.5%) had gonadal dysgenesis. CMA detected 38 CNVs in 16 patients (80%), comprising 12 deletions (31.6%) and 26 duplications (68.4%). Three pathogenic CNVs were detected in 3 patients (15%), whereas 27 variants of uncertain significance were identified in 13 patients (65%).ConclusionIn selected cases, the diagnostic approach should incorporate CMA to elucidate the molecular etiology of DSD. Furthermore, CMA may prove to be an invaluable tool in the search for new genes responsible for DSD.

Detay görüntüle